2001
DOI: 10.2337/diacare.24.3.460
|View full text |Cite
|
Sign up to set email alerts
|

Diagnosing Insulin Resistance in the General Population

Abstract: A weighted combination of two routine laboratory measurements, i.e., fasting insulin and triglycerides, provides a simple means of screening for insulin resistance in the general population.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

10
513
4
18

Year Published

2002
2002
2017
2017

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 631 publications
(545 citation statements)
references
References 20 publications
10
513
4
18
Order By: Relevance
“…This index performed better than other surrogates (including fasting insulin, HOMA‐IR, insulin‐to‐glucose ratio, and the Bennett index) in predicting IR in normoglycemic individuals in New Zealand, with a specificity of 0.91 and a sensitivity of 0.75 10. In addition, there is evidence from a number of studies that increased triglyceride levels are an additional causal risk factor for CVD 33, 34, 35.…”
Section: Discussionmentioning
confidence: 90%
“…This index performed better than other surrogates (including fasting insulin, HOMA‐IR, insulin‐to‐glucose ratio, and the Bennett index) in predicting IR in normoglycemic individuals in New Zealand, with a specificity of 0.91 and a sensitivity of 0.75 10. In addition, there is evidence from a number of studies that increased triglyceride levels are an additional causal risk factor for CVD 33, 34, 35.…”
Section: Discussionmentioning
confidence: 90%
“…29 In one study on the effect of cis-9, trans-11 isomer of CLA in obese men with metabolic syndrome mean values of M/I of 4.2-4.3 M mU À1 l (corrected for bw) were measured, 20 which is lower than corresponding values in the present study. Consequently, few subjects were categorized as being insulin resistant according to cutoff values, which have been suggested for M (Mo28 mmol min À1 lbm À1 ; Stern et al 24 ), for M/I (M/Ip6.3 M mU À1 l; McAuley et al 25 ) and for HOMA (HOMA44.65; Stern et al 24 ). The distribution of M, M/I or HOMA did not change significantly during the 6 months of treatment and no pattern of change in insulin resistance status for CLA-or placebo-supplemented subject was seen.…”
Section: Discussionmentioning
confidence: 99%
“…There was no significant change for M/I adjusted for lbm either within or between treatment groups in the sample that completed two clamps (n ¼ 35) ( Table 2). Using published suggestions for insulin resistance based on M/I adjusted for lbm, 25 four subjects at baseline and three subjects receiving CLA and two receiving placebo at 6 months were categorized as insulin resistant.…”
Section: Clamp Studiesmentioning
confidence: 99%
“…15 Other surrogate methods, including fasting insulin, 16 Bennetts index 17 and the insulin-to-glucose ratio, 18 also demonstrate good concordance with values obtained using the more invasive techniques. [19][20][21] The recently developed quantitative insulin-sensitivity check index (QUICKI), 22 which takes the product of both the reciprocal and the logarithm of fasted insulin and glucose concentrations, gives values that correlate well with the glucose-clamp and minimal model techniques and may provide a better surrogate measure of insulin resistance compared to HOMA IR. 22 The revised version of QUICKI (revised QUICKI) 23 that incorporates a value for fasting nonesterified fatty acids (NEFA) into the QUICKI formula is reported to have a stronger relationship with the glucose clamp than QUICKI alone and therefore may provide an adequate substitute for more sophisticated measures of insulin sensitivity.…”
Section: Introductionmentioning
confidence: 99%